FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for IMITREX (sumatriptan) from GlaxoSmithKline LLC to modify the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imitrex (Sumatriptan)

Snippet

SUPPL AP for IMITREX (SUMATRIPTAN)